Features | Partner Sites | Information | LinkXpress
Sign In
SCHILLER AG
FLUKE BIOMEDICAL
Advantech Europe

Injectable Therapy May Avert Rotator Cuff Injuries

By HospiMedica International staff writers
Posted on 25 Dec 2013
An injectable compound under development could inhibit the breakdown of the supraspinatus tendon, a rotator cuff tendon that is commonly torn in sports.

Researchers at Georgia Tech (Atlanta, USA) and Emory University (Atlanta, GA, USA) are conducting a study to develop improved regenerative medicine strategies to aid repair of tendinopathic tissues. Since one of the hallmarks of tendinopathy is disruption of extracellular matrix (ECM), and particularly collagen, the researcher set out to test which classes of ECM proteases are involved in the tissue degeneration, and develop treatments to deliver inhibitory agents for these enzymes to reduce pathology progression and improve healing.

The central hypothesis of the researchers is that long-term regulation of protease activity in tendinopathy using a protease inhibitor will result in greater tendon tissue structure and mechanical properties. To do so, proteases and inhibitors related to ECM degradation will be tested in vivo in a rat supraspinatus tendon overuse model. The researchers hope to develop a controlled, injectable carrier to achieve local, sustained release of protease inhibitors. The researchers will also study the histology and mechanics of the tendons after healing.

“Normally people focus on treating tendon injuries after the tear has occurred, but we’re focusing on a much earlier stage in the disease,” said lead researcher associate professor Johnna Temenoff, PhD, of the department of Biomedical Engineering. “This is the first time that an injectable therapy specifically designed to interact with tissue at an early disease state has been attempted for this particular tendon injury.”

“We’re studying enzymes that are known to chew up the collagen, and we’re looking at then delivering inhibitors to those enzymes in a local injection in the tendon to try to stop the degradation,” added Dr. Temenoff. “We’re studying the disease in the shoulder, but it’s the same disease that causes tennis elbow, Achilles injuries, and jumper’s knee. It’s the same process, just in different tendons in the body.”

Tendinopathy is a common disorder resulting from repetitive motion in the workplace or during athletic activity that can cause severe pain and long-term disability due to tendon damage in the rotator cuff, a collation of four tendons made of collagen.

Related Links:

Georgia Tech
Emory University



Channels

Critical Care

view channel
Image: The Evzio device and trainer (Photo courtesy of kaléo).

“Rescue Pen” Averts Opioid Overdose Risk

A novel autoinjector formulation of naloxone helps reduce the problem of addiction and abuse of prescription opioids. The Evzio pen is modeled on similar devices used deliver epinephrine to patients... Read more

Women's Health

view channel

Low-Dose Aspirin Will Not Prevent Pregnancy Loss

A new study reveals that in general, low-dose aspirin is not beneficial for future pregnancy outcomes in women with prior pregnancy loss. Researchers at the University at Buffalo (NY, USA) conducted a placebo-controlled trial that included 1,228 women (aged 18-40 years) who were attempting to become pregnant.... Read more

Business

view channel

Infusion Pumps Propel Global Market Upwards

The global infusion pumps market is expected to grow at a compound annual growth rate (CAGR) of 5.3%, reaching an estimated value of USD 7.8 billion in 2019. These are the latest findings of Transparency Market Research (Albany, NY, USA), a global market intelligence company. Infusion pumps are used to deliver therapeutic... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.